Merck Korea to launch easypod, new electronic growth hormone injection device

Published: 2008-09-12 06:59:00

Updated: 2008-09-12 06:59:00

Merck Korea will launch its unique growth hormone injection device, easypod, from next month for the once-daily administration of Saizen (somatropin), the company's recombinant growth hormone deficiency therapy.

A 2007 Gold Medal recipient of the Medical Design Excellence Awards, easypod was d...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK